Universe Pharmaceuticals (UPC) Accounts Payables (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Accounts Payables data on file, last reported at $1.7 billion in Q3 2025.

• For the quarter ending Q3 2025, Accounts Payables fell 66.03% year-over-year to $1.7 billion; the trailing twelve-month figure through Sep 2025 stood at $1.7 billion (down 66.03% YoY), and the FY2025 full-year result was $1.7 billion, down 66.03% from the prior year.
• Accounts Payables fell to $1.7 billion in Q3 2025, from $4.9 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $4.9 billion in Q3 2024 to a low of $3.1 million in Q3 2022.
• A 5-year average of $827.5 million and a median of $6.5 million in 2021 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables tumbled 100.0% in 2021 and soared 107085.58% in 2024, its largest moves.
• Tracing UPC's Accounts Payables over 5 years: stood at $5.3 million in 2021, then sank by 42.09% to $3.1 million in 2022, then jumped by 49.1% to $4.6 million in 2023, then soared by 107085.58% to $4.9 billion in 2024, then slumped by 66.03% to $1.7 billion in 2025.
• Business Quant data shows UPC's Accounts Payables at $1.7 billion in Q3 2025, $4.9 billion in Q3 2024, and $7.8 million in Q1 2024.